Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Tropheryma Whipplei | Case report

Whipple disease diagnosed by enteroscopy: first case report in Colombia of an underdiagnosed disease and literature review

Authors: Margarita Rey R., Luis Alejandro Orozco, Katherine Marrugo, Rocio López, Erika D. Pérez-Riveros, José De la Hoz-Valle, Fernando Sierra-Arango

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

Whipple’s disease is a rare systemic disease caused by a gram-positive bacillus called Tropheryma whipplei. First described in 1907 as an intestinal lipodystrophy with histological finding of vacuoles in the macrophages of the intestinal mucous. Usually the symptoms are localized according to the compromised organ. The differential diagnosis is wide. It can be fatal without proper treatment. Recurrence can occur in up to 33% of the cases and usually compromises the neurological system.

Case presentation

This article reports the case of a 46-year-old female patient with a history of a 6-month hypochromic microcytic anemia of unknown cause. She consulted for a 6-months oppressive abdominal pain located in the mesogastrium as well as abdominal distention associated with nausea and liquid stools; in addition, she had an 8-month small and medium joint pain, without edema or erythema. Physical examination without relevant findings. Multiple esophagogastroduodenoscopies with normal gastric and duodenal biopsies findings and a normal colonoscopy were performed. Endoscope capsule showed red spots in the duodenum and ulcerations in the jejunum and proximal ileum covered by fibrin; histological report showed macrophages with positive periodic acid-schiff reaction staining (PAS staining), disgnosing Whipple’s disease. Antibiotics were initiated. The patient is currently in the second phase of treatment without gastrointestinal and joint symptoms.

Conclusion

This is the first case reported in Colombia. It is a rare entity and difficult to diagnose reason why it is important to continue with clinical investigations to give more clarity about the onset and appropriate diagnose to avoid the delay in treatment of this entity.
Literature
1.
go back to reference Sellin J, Beales ILP. Whipple’s disease: a well-done outcome to a rare disease. Dig Dis Sci. 2019;64(1):9–11.CrossRef Sellin J, Beales ILP. Whipple’s disease: a well-done outcome to a rare disease. Dig Dis Sci. 2019;64(1):9–11.CrossRef
2.
go back to reference Pyrgioti MKA. Whipple’s disease: a review. Ann Gastroenterol. 2004;17:43–50. Pyrgioti MKA. Whipple’s disease: a review. Ann Gastroenterol. 2004;17:43–50.
3.
go back to reference La Scola B, Altwegg M, Mallet MN, Fournier PE, Fenollar F, Raoult D. Description of Tropheryma whipplei gen. Nov., sp. nov., the Whipple’s disease bacillus. Int J Syst Evol Microbiol. 2001;51(4):1471–9.CrossRef La Scola B, Altwegg M, Mallet MN, Fournier PE, Fenollar F, Raoult D. Description of Tropheryma whipplei gen. Nov., sp. nov., the Whipple’s disease bacillus. Int J Syst Evol Microbiol. 2001;51(4):1471–9.CrossRef
4.
go back to reference Ramzan NN. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med. 1997;126(7):520.CrossRef Ramzan NN. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med. 1997;126(7):520.CrossRef
5.
go back to reference Black-Schaffer B. The Tinctoral demonstration of a glycoprotein in Whipple’s disease. Exp Biol Med. 1949;72(1):225–7.CrossRef Black-Schaffer B. The Tinctoral demonstration of a glycoprotein in Whipple’s disease. Exp Biol Med. 1949;72(1):225–7.CrossRef
6.
go back to reference Fantry GT, Fantry LE, James SP. Chronic infections of the small intestine. In: Yamada T, editor. Textbook of gastroenterology. Oxford, UK: Blackwell Publishing Ltd.; 2008. p. 1225–44.CrossRef Fantry GT, Fantry LE, James SP. Chronic infections of the small intestine. In: Yamada T, editor. Textbook of gastroenterology. Oxford, UK: Blackwell Publishing Ltd.; 2008. p. 1225–44.CrossRef
7.
go back to reference Elchert JA, Mansoor E, Abou-Saleh M, Cooper GS. Epidemiology of Whipple’s disease in the USA between 2012 and 2017: a population-based National Study. Dig Dis Sci. 2019;64(5):1305–11.CrossRef Elchert JA, Mansoor E, Abou-Saleh M, Cooper GS. Epidemiology of Whipple’s disease in the USA between 2012 and 2017: a population-based National Study. Dig Dis Sci. 2019;64(5):1305–11.CrossRef
8.
go back to reference Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology. 2009;136(7):2289–94.CrossRef Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology. 2009;136(7):2289–94.CrossRef
9.
go back to reference Fenollar F, Keita AK, Buffet S, Raoult D. Intrafamilial Circulation of Tropheryma whipplei, France. Emerg Infect Dis. 2012;18(6):1–7. Fenollar F, Keita AK, Buffet S, Raoult D. Intrafamilial Circulation of Tropheryma whipplei, France. Emerg Infect Dis. 2012;18(6):1–7.
10.
go back to reference Fenollar F, Puéchal X, Raoult D. Whipple’s disease. N Engl J Med. 2007;356(1):55–66.CrossRef Fenollar F, Puéchal X, Raoult D. Whipple’s disease. N Engl J Med. 2007;356(1):55–66.CrossRef
11.
go back to reference Puéchal X. Whipple disease and arthritis. Curr Opin Rheumatol. 2001;13(1):74–9.CrossRef Puéchal X. Whipple disease and arthritis. Curr Opin Rheumatol. 2001;13(1):74–9.CrossRef
12.
go back to reference Keinath RD, Merrell DE, Vlietstra R, Dobbins WO. Antibiotic treatment and relapse in Whipple’s disease. Gastroenterology. 1985;88(6):1867–73.CrossRef Keinath RD, Merrell DE, Vlietstra R, Dobbins WO. Antibiotic treatment and relapse in Whipple’s disease. Gastroenterology. 1985;88(6):1867–73.CrossRef
13.
go back to reference Dolmans RAV, Boel CHE, Lacle MM, Kusters JG. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev. 2017;30(2):529–55.CrossRef Dolmans RAV, Boel CHE, Lacle MM, Kusters JG. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev. 2017;30(2):529–55.CrossRef
14.
15.
go back to reference Martínez-Sánchez A. S-CFL, Fernández-Díez S. S-SML, Baki W. Asteinza-Daganzo M., Esteban J.M. R-D-RE. Atypical diagnosis by endoscopic capsule: Whipple’s disease. Rev Esp Enfermedades Dig 2016;108:158–62. Martínez-Sánchez A. S-CFL, Fernández-Díez S. S-SML, Baki W. Asteinza-Daganzo M., Esteban J.M. R-D-RE. Atypical diagnosis by endoscopic capsule: Whipple’s disease. Rev Esp Enfermedades Dig 2016;108:158–62.
16.
go back to reference Bureš J, Kopáčová M, Douda T, Bártová J, Tomš J, Rejchrt S, et al. Whipple’s disease: our own experience and review of the literature. Gastroenterol Res Pract. 2013;2013:1–10.CrossRef Bureš J, Kopáčová M, Douda T, Bártová J, Tomš J, Rejchrt S, et al. Whipple’s disease: our own experience and review of the literature. Gastroenterol Res Pract. 2013;2013:1–10.CrossRef
17.
go back to reference Obst W, von Arnim U, Malfertheiner P. Whipple’s disease. Viszeralmedizin. 2014;30(3):5–5.CrossRef Obst W, von Arnim U, Malfertheiner P. Whipple’s disease. Viszeralmedizin. 2014;30(3):5–5.CrossRef
18.
go back to reference Marth T, Moos V, Müller C, Biagi F, Schneider T. Tropheryma whipplei infection and Whipple’s disease. Lancet Infect Dis. 2016;16(3):e13–22.CrossRef Marth T, Moos V, Müller C, Biagi F, Schneider T. Tropheryma whipplei infection and Whipple’s disease. Lancet Infect Dis. 2016;16(3):e13–22.CrossRef
19.
go back to reference Saito H, Shiode J, Ohya S, Yao A, Saito S, Fujii M, et al. Whipple’s disease with long-term endoscopic follow-up. Intern Med. 2018;57(12):1707–13.CrossRef Saito H, Shiode J, Ohya S, Yao A, Saito S, Fujii M, et al. Whipple’s disease with long-term endoscopic follow-up. Intern Med. 2018;57(12):1707–13.CrossRef
Metadata
Title
Whipple disease diagnosed by enteroscopy: first case report in Colombia of an underdiagnosed disease and literature review
Authors
Margarita Rey R.
Luis Alejandro Orozco
Katherine Marrugo
Rocio López
Erika D. Pérez-Riveros
José De la Hoz-Valle
Fernando Sierra-Arango
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01302-2

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine